Department of Nephrology, Japan Community Health Care Organization Kyushu Hospital, 1-8-1, Kishinoura, Yahatanishi-Ku, Kitakyushu-Shi, Fukuoka, 806-8501, Japan.
Department of Nephrology, Steel Memorial Yahata Hospital, Kitakyushu, Japan.
CEN Case Rep. 2024 Oct;13(5):381-390. doi: 10.1007/s13730-024-00856-4. Epub 2024 Mar 4.
The incidence rate of malignancy in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is higher than that in the general population. Malignancy has been indicated to be a risk factor or inducer of AAV. Herein, we report the case of a healthy 84-year-old man with seronegative microscopic polyangiitis (MPA) after the diagnosis of renal pelvic carcinoma. Four weeks before admission, his estimated glomerular filtration rate (eGFR) was 85 ml/min/1.73 m, and no hematuria or proteinuria was detected. Renal biopsy on admission revealed invasive urothelial carcinoma of the right renal pelvis. On day 15, his eGFR decreased to 30 ml/min/1.73 m without any incitement. The renal specimen extracted via right robot-assisted nephroureterectomy indicated the presence of ANCA-associated glomerulonephritis. On day 37, urinary protein/urinary creatinine level of 6.48 g/gCre, serum albumin level of 2.1 mg/dL, and eGFR of 20 ml/min/1.73 m indicated the presence of nephrotic syndrome. His blood sputum was analyzed via chest computed tomography, which revealed alveolar hemorrhage. Although his myeloperoxidase-ANCA was negative, he was diagnosed with MPA based on the 2022 American College of Rheumatology/European League Against Rheumatism classification criteria. This is the first case report of MPA or AAV complicated with renal pelvic carcinoma. The clinical indicators demonstrated that renal pelvic carcinoma preceded the onset of MPA. The spatial proximity of both diseases indicated that renal pelvic carcinoma had some influence on MPA development via the mechanism of inflammatory cytokines or neutrophil extracellular traps. Our report may be useful in elucidating the mechanism of MPA development.
抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)患者的恶性肿瘤发病率高于普通人群。恶性肿瘤已被认为是 AAV 的风险因素或诱导因素。在此,我们报告了一例健康的 84 岁男性,他在被诊断为肾盂癌后患有血清阴性显微镜下多血管炎(MPA)。入院前 4 周,他的估算肾小球滤过率(eGFR)为 85 ml/min/1.73 m,未检测到血尿或蛋白尿。入院时的肾活检显示右侧肾盂浸润性尿路上皮癌。第 15 天,他的 eGFR 下降至 30 ml/min/1.73 m,没有任何诱因。通过右侧机器人辅助肾输尿管切除术提取的肾标本提示存在与 ANCA 相关的肾小球肾炎。第 37 天,尿蛋白/尿肌酐水平为 6.48 g/gCre,血清白蛋白水平为 2.1 mg/dL,eGFR 为 20 ml/min/1.73 m,表明存在肾病综合征。他的血液痰通过胸部计算机断层扫描进行了分析,结果显示肺泡出血。尽管他的髓过氧化物酶-ANCA 为阴性,但根据 2022 年美国风湿病学会/欧洲抗风湿病联盟分类标准,他被诊断为 MPA。这是首例 MPA 或 AAV 并发肾盂癌的病例报告。临床指标表明肾盂癌先于 MPA 发病。两种疾病的空间接近表明,通过炎症细胞因子或中性粒细胞细胞外陷阱的机制,肾盂癌对 MPA 的发展有一定影响。我们的报告可能有助于阐明 MPA 发展的机制。